Vetsys Pharmaceutical
Vetsys Pharmaceutical
Toronto, as Canada’s primary economic engine, has emerged as a critical hub for the veterinary pharmaceutical industry. The Greater Toronto Area (GTA) and the nearby Guelph-Waterloo corridor form one of the densest animal health clusters in North America. As a leading Intramammary Infusions Factory & Exporter, we leverage Toronto's world-class logistics and research infrastructure to deliver life-saving treatments to dairy farms globally.
The demand for specialized intramammary infusions in Ontario—home to over 3,000 dairy farms—has driven local factories to adopt AI-integrated manufacturing and rigorous GMP protocols. Our facility in Toronto serves as a gateway for exporting high-grade bovine health products, ensuring that the "Toronto Quality Seal" is recognized from Europe to Southeast Asia.
Zhengzhou Vetsys Pharmaceutical Co., Ltd. (Vetsys), established in 2005, is a powerhouse in the animal pharmaceutical sector. With a registered capital of 30 million RMB, we have spent nearly two decades perfecting the art of veterinary medicine.
Vetsys distinguishes itself through a strong emphasis on technological development. Our independent research institute features five specialized laboratories staffed by world-class scientists, allowing us to pivot quickly to market demands like Toronto's selective dry cow therapy trends.
Quality is our cornerstone. Adhering to rigorous GMP standards, Vetsys ensures every intramammary infusion undergoes extensive QC checks. This commitment has made us one of the top animal pharmaceutical producers, achieving USD 20 million in annual sales by 2015.
Our long-term vision includes green technologies and global expansion. We are actively exploring international partnerships from our Toronto hub to bring safe, effective animal drugs to every corner of the globe.
In the Toronto veterinary corridor, we are seeing three major shifts:
From Oxford County to Wellington County, the application of our intramammary infusions is vital for maintaining the high standards of Canada's dairy industry. High-yield Holsteins in the Toronto periphery require specialized care to prevent bovine mastitis, a condition that costs the global dairy industry billions annually.
Our infusions, such as the Ampicillin and Cloxacillin formula, are engineered for high bioavailability within the udder tissue. Whether it is prophylactic treatment during the "Dry Period" or acute intervention during "Lactation," our Toronto-exported products provide the pharmacological precision needed for modern herd management.
Request Technical DatasheetOur manufacturing processes utilize AI-monitored environments to ensure sterile filling and packaging of every infusion tube.
Intramammary infusions represent a critical delivery mechanism for antibiotics and anti-inflammatory agents directly into the udder cistern. In the competitive livestock markets of Toronto and beyond, the efficacy of these treatments is paramount. Our products utilize Cefquinome Sulfate, a fourth-generation cephalosporin, specifically chosen for its broad-spectrum activity against both Gram-positive and Gram-negative pathogens including Staphylococcus aureus and Escherichia coli.
The pharmacokinetics of our Toronto-produced infusions are optimized for extended release. For dry cow therapy, the base is formulated to maintain therapeutic concentrations for several weeks, creating a physical and chemical barrier against new intramammary infections (IMI) during the involution phase. Conversely, our lactating cow infusions are designed for rapid absorption and minimal milk discard times, a crucial economic factor for Ontario dairy producers.
As a leading exporter in Toronto, we ensure that every batch is tested for syringeability—ensuring that even in the cold Canadian winters, the ointment remains fluid enough for easy administration without causing stress to the animal. Our commitment to E-E-A-T principles means we don't just sell medicine; we provide a clinical solution backed by decades of laboratory research and real-world farm data.
The strategic location of our Toronto hub allows us to sync with global health trends, such as the One Health Initiative. We are constantly innovating our Compound Amoxicillin formulas to include Sulbactam Sodium, which inhibits beta-lactamase enzymes, effectively bypassing antibiotic resistance. This technical edge is why Vetsys remains a trusted partner for veterinary surgeons and large-scale farm managers worldwide.
At Vetsys, we are driven by our mission to improve animal health through continuous innovation, world-class quality, and sustainable practices. We remain committed to creating value for our customers, employees, and society as we continue to shape the future of animal healthcare in Toronto and the global market.
Connect with our Toronto Export Team
